The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms

[1]  A. Johri,et al.  The activity of RTA2, a downstream effector of the calcineurin pathway, is required during tunicamycin-induced ER stress response in Candida albicans. , 2015, FEMS yeast research.

[2]  B. Kjellerup,et al.  Elimination of Bloodstream Infections Associated with Candida albicans Biofilm in Intravascular Catheters , 2015, Pathogens.

[3]  A. Rodrigues,et al.  Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. , 2015, Front. Microbiol..

[4]  N. Wijayanti,et al.  Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth. , 2015, Tropical biomedicine.

[5]  Dayong Wang,et al.  Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida albicans , 2015, PloS one.

[6]  S. Falk,et al.  Nylon-3 polymers active against drug-resistant Candida albicans biofilms. , 2015, Journal of the American Chemical Society.

[7]  B. P. Dias Filho,et al.  Effects of fluconazole treatment of mice infected with fluconazole-susceptible and -resistant Candida tropicalis on fungal cell surface hydrophobicity, adhesion and biofilm formation , 2015, Indian journal of medical microbiology.

[8]  P. Juvvadi,et al.  Calcineurin as a Multifunctional Regulator: Unraveling Novel Functions in Fungal Stress Responses, Hyphal Growth, Drug Resistance, and Pathogenesis. , 2014, Fungal biology reviews.

[9]  D. Chorvat,et al.  The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant Candida albicans , 2014, Folia Microbiologica.

[10]  M. Falleni,et al.  Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity , 2014, BMC Microbiology.

[11]  Shuyuan Liu,et al.  Synergistic effect of fluconazole and doxycycline against Candida albicans biofilms resulting from calcium fluctuation and downregulation of fluconazole-inducible efflux pump gene overexpression. , 2014, Journal of medical microbiology.

[12]  J. Su,et al.  Human serum inhibits adhesion and biofilm formation in Candida albicans , 2014, BMC Microbiology.

[13]  E. Mylonakis,et al.  In Vitro and In Vivo Activities of Pterostilbene against Candida albicans Biofilms , 2014, Antimicrobial Agents and Chemotherapy.

[14]  C. Rickard,et al.  Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective , 2013, International journal of nanomedicine.

[15]  M. Blanco-Blanco,et al.  Determination of biofilm production by Candida tropicalis isolated from hospitalized patients and its relation to cellular surface hydrophobicity, plastic adherence and filamentation ability , 2013, Yeast.

[16]  Ping Liu,et al.  Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers. , 2013, FEMS yeast research.

[17]  Beiqin Yu,et al.  Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. , 2013, The Journal of antimicrobial chemotherapy.

[18]  J. Heitman,et al.  Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans , 2013, PloS one.

[19]  Lan Yan,et al.  ECM17-dependent methionine/cysteine biosynthesis contributes to biofilm formation in Candida albicans. , 2013, Fungal genetics and biology : FG & B.

[20]  N. Chauhan,et al.  Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A , 2012, Annals of Clinical Microbiology and Antimicrobials.

[21]  J. Heitman,et al.  Calcineurin Is Required for Pseudohyphal Growth, Virulence, and Drug Resistance in Candida lusitaniae , 2012, PloS one.

[22]  P. van Dijck,et al.  Potent Synergistic Effect of Doxycycline with Fluconazole against Candida albicans Is Mediated by Interference with Iron Homeostasis , 2012, Antimicrobial Agents and Chemotherapy.

[23]  R. Rajendran,et al.  Fungal Biofilm Resistance , 2012, International journal of microbiology.

[24]  F. Lanni,et al.  Portrait of Candida albicans Adherence Regulators , 2012, PLoS pathogens.

[25]  P. Cobine,et al.  Calcium Increases Xylella fastidiosa Surface Attachment, Biofilm Formation, and Twitching Motility , 2011, Applied and Environmental Microbiology.

[26]  Li-hua Yu,et al.  Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm , 2011, Antimicrobial Agents and Chemotherapy.

[27]  Mingchun Li,et al.  Alkaline stress triggers an immediate calcium fluctuation in Candida albicans mediated by Rim101p and Crz1p transcription factors. , 2011, FEMS yeast research.

[28]  S. Filler,et al.  Candida albicans Als3, a Multifunctional Adhesin and Invasin , 2010, Eukaryotic Cell.

[29]  Ping Liu,et al.  The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. , 2010, FEMS yeast research.

[30]  K. Hirota,et al.  Effect of substrate surface hydrophobicity on the adherence of yeast and hyphal Candida , 2010, Mycoses.

[31]  Yong-qiang Zhang,et al.  Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans , 2010, Antimicrobial Agents and Chemotherapy.

[32]  J. Heitman,et al.  Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence. , 2010, Fungal genetics and biology : FG & B.

[33]  J. Bagg,et al.  Reducing the incidence of denture stomatitis: are denture cleansers sufficient? , 2010, Journal of prosthodontics : official journal of the American College of Prosthodontists.

[34]  J. Bouchara,et al.  Adherence mechanisms in human pathogenic fungi. , 2008, Medical mycology.

[35]  G. Di Bonaventura,et al.  Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. , 2008, FEMS microbiology letters.

[36]  A. Mitchell,et al.  Complementary Adhesin Function in C. albicans Biofilm Formation , 2008, Current Biology.

[37]  L. Cowen,et al.  The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype , 2008, Nature Reviews Microbiology.

[38]  G. Robertson,et al.  Bacterial and fungal biofilm infections. , 2008, Annual review of medicine.

[39]  J. Heitman,et al.  Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms , 2008, Antimicrobial Agents and Chemotherapy.

[40]  J. Lopez-Ribot,et al.  A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing , 2008, Nature Protocols.

[41]  S. Baliga,et al.  Candida biofilms in medical devices: evolving trends. , 2007, Kathmandu University medical journal.

[42]  J. Heitman,et al.  Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections , 2007, Nature Reviews Microbiology.

[43]  A. Mitchell,et al.  How to build a biofilm: a fungal perspective. , 2006, Current opinion in microbiology.

[44]  A. Mitchell,et al.  Genetics and genomics of Candida albicans biofilm formation , 2006, Cellular microbiology.

[45]  J. Heitman,et al.  Calcineurin Promotes Infection of the Cornea by Candida albicans and Can Be Targeted To Enhance Fluconazole Therapy , 2006, Antimicrobial Agents and Chemotherapy.

[46]  Stefan Bentink,et al.  Role of Calcineurin in Stress Resistance, Morphogenesis, and Virulence of a Candida albicans Wild-Type Strain , 2006, Infection and Immunity.

[47]  William R. Kirkpatrick,et al.  Calcineurin Controls Growth, Morphology, and Pathogenicity in Aspergillus fumigatus , 2006, Eukaryotic Cell.

[48]  J. Heitman,et al.  Immunotherapy with Tacrolimus (FK506) Does Not Select for Resistance to Calcineurin Inhibitors in Candida albicans Isolates from Liver Transplant Patients , 2006, Antimicrobial Agents and Chemotherapy.

[49]  D. Sanglard,et al.  CRZ1, a target of the calcineurin pathway in Candida albicans , 2006, Molecular microbiology.

[50]  James B. Anderson.  Evolution of antifungal-drug resistance: mechanisms and pathogen fitness , 2005, Nature Reviews Microbiology.

[51]  J. Heitman,et al.  The Calcineurin Target, Crz1, Functions in Azole Tolerance but Is Not Required for Virulence of Candida albicans , 2004, Infection and Immunity.

[52]  C. d’Enfert,et al.  Candida albicans Biofilms: a Developmental State Associated With Specific and Stable Gene Expression Patterns , 2004, Eukaryotic Cell.

[53]  R. Darouiche,et al.  Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.

[54]  M. Ghannoum,et al.  Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols , 2003, Infection and Immunity.

[55]  D. Sanglard,et al.  Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1 Genes , 2003, Antimicrobial Agents and Chemotherapy.

[56]  J. Heitman,et al.  Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei , 2003, Antimicrobial Agents and Chemotherapy.

[57]  L. Samaranayake,et al.  Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[58]  Joseph Heitman,et al.  Calcineurin is essential for survival during membrane stress in Candida albicans , 2002, The EMBO journal.

[59]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[60]  D. Sanglard,et al.  A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.

[61]  D. Sanglard,et al.  Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans , 2000, Antimicrobial Agents and Chemotherapy.

[62]  S. Kohno,et al.  Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans , 2000, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[63]  R. Cannon,et al.  Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance , 1996, Antimicrobial agents and chemotherapy.

[64]  T. Davis,et al.  Ca2+-calmodulin promotes survival of pheromone-induced growth arrest by activation of calcineurin and Ca2+-calmodulin-dependent protein kinase , 1996, Molecular and cellular biology.

[65]  L. Samaranayake,et al.  Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[66]  H. Vanden Bossche.  Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. , 1985, Current topics in medical mycology.